Morningstar® Stock Report™

Walgreens Boots Alliance Inc WBA

Último Precio
17.29
Cambio del día
-0.06|-0.35%

a 08/05/2024
09:56:25 EDT | USD  Retraso mínimo: 15 minutos

Bid/OffersRango del DíaVolumen90d Ave VolCapitalización
17.29 - 17.3017.23 - 17.36710,22411,571,53014.97Bil
Último Cierre52 Week RangeP/UDividendo %ISIN
17.3517.23 - 32.8932.859.74US9314271084

Cotización Walgreens Boots Alliance Inc

Mr. Lee Davidson, Head of Quantitative Research
The conduct of Morningstar's analysts is governed by Morningstar's Code of Ethics, Securities Trading and Disclosure Policy, and Investment Research Integrity Policy. For information regarding conflicts of interest, please click here.
Fair Value is derived from a detailed projection of a company’s future cash flows. Analysts create custom industry and company assumptions to feed income statement, balance sheet, and capital investment assumptions into a proprietary discounted cash flow modeling template. Scenario analysis, in-depth competitive advantage analysis, and a variety of other analytical tools are used to augment the discounted cash flow process. Combining analysts’ financial forecasts with the firm’s economic moat helps us assess how long returns on invested capital are likely to exceed the firm’s cost of capital. Because we are modeling free cash flow to the firm—representing cash available to provide a return to all capital providers—we discount future cash flows using the weighted average of the costs of equity, debt, and preferred stock (and any other funding sources), using expected future proportionate long-term, market-value weights. If our base-case assumptions are true the market price will converge on our fair value estimate over time, generally within three years. Investments in securities are subject to market and other risks. Past performance of a security may or may not be sustained in future and is no indication of future performance. For detail information about the Qualitative Fair Value, please click here.
Cuentas Financieras
202120222023
Más...
Cuenta de Resultados
Ingresos132,509.00132,703.00139,081.00
Resultado Operativo3,481.00970.00-7,133.00
Resultado Neto2,542.004,337.00-3,080.00
Beneficio Básico por Acción2.945.02-3.57
Num Medio Acciones diluidas en circulación866866863
Balance
Activo Corriente15,814.0016,902.0015,503.00
Activos no corrientes65,471.0073,222.0081,125.00
Total Activo 81,285.0090,124.0096,628.00
Pasivo corriente22,054.0022,583.0024,535.00
Total Pasivo---
Capital Total23,419.0025,275.0020,021.00
Flujo de Caja
Flujo de caja operativo5,555.003,899.002,258.00
Inversiones de Capital-1,379.00-1,734.00-2,117.00
Flujo de Caja Libre4,176.002,165.00141.00

En millones, excepto "EPS básico". La moneda es USD.

Perfil de la compañía

Walgreens Boots Alliance is one of the largest retail pharmacy chains in the U.S., with over 8,500 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the U.S. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.

Sector

Atención sanitaria

Industria

Pharmaceutical Retailers

Estilo de acciones

Media-Valor

Fin Ejercicio Fiscal

agosto

Empleados

331,000
Principales Características
Más...
Precio/Beneficio 12 m-2.48
Precio/Valor contable1.11
Precio/Ventas TTM0.10
Crec Ingresos (media 3 a)-0.11
Crec BPA (media 3 a)-
Margen operativo-5.13
Margen neto-2.21
ROE 12 m-13.60
Deuda/Fondos propios1.51
Dividendos
AntÚltimo
Fecha declarada04/01/2425/04/24
Ex-Div16/02/2420/05/24
Pagado12/03/2412/06/24
Cantidad0.250.25
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures